Samsara Other Income (Expense) increased by 71.2% to $18.52M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 89.1%, from $9.79M to $18.52M. Over 4 years (FY 2022 to FY 2026), Other Income (Expense) shows an upward trend with a 1178.8% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $160.00K | $224.00K | -$143.00K | -$243.00K | -$60.00K | $1.54M | $5.61M | $8.53M | $8.90M | $10.22M | $9.38M | $11.47M | $10.08M | $9.63M | $10.06M | $9.79M | $12.72M | $11.43M | $10.82M | $18.52M |
| QoQ Change | — | +40.0% | -163.8% | -69.9% | +75.3% | >999% | +264.2% | +51.9% | +4.3% | +14.9% | -8.2% | +22.3% | -12.1% | -4.5% | +4.5% | -2.6% | +29.9% | -10.2% | -5.3% | +71.2% |
| YoY Change | — | — | — | — | -137.5% | +587.9% | >999% | >999% | >999% | +563.2% | +67.1% | +34.5% | +13.4% | -5.8% | +7.2% | -14.6% | +26.2% | +18.7% | +7.5% | +89.1% |